Labeled with carbon-11, N-(2-chloro-5-thiomethylphenyl)-N′-(3-methoxyphenyl)-N′methylguanidine ([ 11 C]GMOM) is currently the only positron emission tomography (PET) tracer that has shown selectivity for the ion-channel site of N-methyl-D-aspartate (NMDA) receptors in human imaging studies. The present study reports on the selectivity profile and in vitro binding properties of GMOM. The compound was screened on a panel of 80 targets, and labeled with tritium ([ 3 H]GMOM). The binding properties of [ 3 H]GMOM were compared to those of the reference ion-channel ligand [ 3 H](+)-dizocilpine maleate ([ 3 H]MK-801), in a set of concentration-response, homologous and heterologous inhibition, and association kinetics assays, performed with repeatedly washed rat forebrain preparations. GMOM was at least 70-fold more selective for NMDA receptors compared to all other targets examined. In homologous inhibition and concentration-response assays, the binding of [ 3 H] GMOM was regulated by NMDA receptor agonists, albeit in a less prominent manner compared to [ 3 H]MK-801. Scatchard transformation of homologous inhibition data produced concave upward curves for [ 3 H]GMOM and [ 3 H]MK-801. The radioligands showed bi-exponential association kinetics in the presence of 100 μmol L −1 L-glutamate/30 μmol L −1 glycine. [ 3 H]GMOM (3 nmol L −1 and 10 nmol L −1 ) was inhibited with dual affinity by (+)-MK-801, (R,S)-ketamine and memantine, in both presence and absence of agonists. [ 3 H]MK-801 (2 nmol L −1 ) was inhibited in a monophasic manner by GMOM under baseline and combined agonist conditions, Abbreviations: CGP 78608, [(1S)-1-[[ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
with an IC 50 value of~19 nmol L −1 . The non-linear Scatchard plots, biphasic inhibition by open channel blockers, and bi-exponential kinetics of [ 3 H]GMOM indicate a complex mechanism of interaction with the NMDA receptor ionophore. The implications for quantifying the PET signal of [ 11 C]GMOM are discussed. The ionotropic NMDA receptors possess at least six distinct sites for the recognition of endogenous ligands, including sites for the agonist L-glutamate, the co-agonists glycine and D-serine, and modulators of receptor function as diverse as polyamines, steroids, metal ions, and protons. 4 Of the multiple binding sites, considerable effort has been directed on imaging the site within the pore of the NMDA receptor ion-channel. Due to its unique physical location, the intrachannel site is primarily accessible when the NMDA receptors are in an open conformation, that is activated by the agonists L-glutamate and glycine/D-serine. 5, 6 Thus, PET tracer uptake at the ion-channel site should be proportional to the amount of activated NMDA receptors, permitting the evaluation of their functional state in vivo. 7. N, N΄-di-substituted guanidines were first described as open channel blockers of the NMDA receptors by electrophysiology, in 1989. 8 To date, diarylguanidine analogs constitute the most promising class of compounds for the functional imaging of NMDA receptors. Unlike early derivatives of phencyclidine and (+)-dizocilpine maleate (MK-801), which were unsuitable for PET due to high lipophilicity and non-specific uptake, [9] [10] [11] 15 are NMDA-targeting tracers of moderate lipophilicity and high affinity (Figure 1) , which have exhibited quantifiable brain uptake in human PET studies). [16] [17] [18] [19] [ 11 C]GMOM, in particular, is currently the only diarylguanidine tracer that has shown selectivity for the NMDA receptors in vivo, as evidenced by a F I G U R E 1 Structures and affinity values of NMDA receptor PET tracers used in human imaging studies reduction in the tracer's net influx rate following the administration of an S-ketamine challenge to healthy human volunteers. 19 Despite showing considerable potential as a PET tracer, [ 11 C] GMOM remains poorly characterized in terms of its in vitro binding profile. GMOM is known to possess a high-affinity binding site that is associated with the reference ion-channel blocker of NMDA receptors, [ 3 H](+)-dizocilpine maleate ([ 3 H]MK-801). In competition binding assays against [ 3 H]MK-801, the inhibition constant (Ki) of GMOM has been reported to range from 5.2 nmol L −1 to 21.7 nmol L −1 . 12, 13 Apart from this information, however, no further details on GMOM's interaction with the NMDA receptor channel are currently available.
K E Y W O R D S
The goal of the present study was to examine the selectivity and in vitro binding properties of the diarylguanidine GMOM. The compound was labeled with tritium ([ 3 H]GMOM), and its binding profile compared with that of [ 3 H]MK-801 in a set of concentrationresponse, inhibition, and association kinetics experiments.
| MATERIALS AND METHODS

| Selectivity profile of GMOM
The pharmacological selectivity of GMOM was evaluated at CEREP S.A. (Poitiers, France), using a broad screen of 79 targets, comprising neurotransmitter receptors and transporters, and ion-channels (Table S1 ). Binding of GMOM to the ifenprodil site of NMDA receptors was evaluated in-house, using a previously detailed assay. 20 A percent (%) inhibition of control specific binding was initially calculated for each target, using a single concentration of GMOM (10 μmol L −1 ). The affinity of GMOM for targets showing ≥50% inhibition of control binding in the primary screen was subsequently derived from full concentration-response inhibition curves, which were obtained by using at least eight concentrations of GMOM. Hill coefficients (nH) and half-maximal inhibitory concentrations (IC 50 ) were derived from the competition binding experiments by non-linear regression analysis, using software developed at CEREP (Hill software). IC 50 values were converted to inhibitory constant values (K i ) with the Cheng and Prusoff 21 equation for binding assays:
is radioligand concentration in the assay and K d the equilibrium dissociation constant of the radioligand for its corresponding target. The K d values of the reference radioligands were obtained from saturation binding experiments, which were run in parallel to the competition studies. Details of the CEREP selectivity assays are available from www.cerep.fr. 
| Synthesis of [ 3 H]GMOM
| Animals and membrane preparation
All procedures complied with European Commission Directive 2010/ 63/EU, regulating animal research, and were approved by the institutional animal ethics committee of the VUmc. Male Wistar rats (140-160 g) were purchased from Harlan Laboratories, Venray, the Netherlands. The animals were housed in groups of 4, under a 12 hour light-
. i: DMF, NaOH (5 mol L −1 ), 80°C, 30 minutes dark cycle (lights on: 8 AM) and controlled temperature (21 ± 2°C) and humidity conditions (50 ± 10%). Food and water were available ad libitum (Teklad Global 16% Protein Rodent Diet, Harlan Laboratories).
Extensively washed, crude synaptic membranes were prepared as detailed previously. 22 Animals were killed by decapitation, and the cerebral cortices and hippocampi immediately removed and homogenized in a 15-fold excess (v/w) of ice-cold 0.32 mol L −1 sucrose, using a DUALL tissue grinder (20 strokes, 800 rpm; VWR, Amsterdam, the Netherlands). The homogenate was centrifuged at 1000 g for 10 min- Following incubation, the suspension was centrifuged at 165 000 g for 20 minutes, and the pellets frozen at −80°C for 1-3 days. For binding experiments, the pellets were thawed to room temperature and suspended in 30 vol of dH 2 O. The membrane suspension was incubated at 37°C for 1 hours and washed twice for 30 minutes at 165 000 g.
After the final centrifugation step, pellets were diluted in 80 vol of assay buffer (5 mmol L −1 Tris-HCl, pH 7.4), corresponding to~5 mg of wet tissue weight, and used in radioligand binding assays. Protein concentration was determined with the BCA protein kit, and bovine serum albumin as standard (ThermoFisher Scientific, Breda, the Netherlands). Duchefa Farma BV, Haarlem, the Netherlands) was used to define non-specific binding (NSB) in these preliminary studies. The pH dependence of [ 3 H]GMOM binding (2 nmol L −1 ) was assessed under baseline conditions (no added L-glutamate/glycine) following 20 hours incubations in assay buffer, using 10 μmol L −1 unlabeled GMOM to define NSB (pH range: 6.5-8.5). Based on these preliminary studies, the methods described below represent optimized binding conditions.
| Binding studies
| Optimization of binding conditions
| Regulation of radioligand binding by NMDA receptor agonists/antagonists
The effects of L-glutamate and glycine on the binding of 10 nmol L −1 Experiments were conducted in triplicate, 3-4 independent times. 
| Homologous inhibition studies
| Heterologous inhibition studies
The ability of increasing concentrations of MK-801 (10 pmol L −1 - All competitors were dissolved as 10 mmol L −1 stock solutions in DMSO, with the exception of (R,S)-ketamine, which was prepared as 1 mol L −1 stock solution in dH 2 O, containing 10% ethanol. Experiments were repeated 3-9 independent times. IC 50 values were derived from the concentration-inhibition curves by fitting the raw data to the one-or two-sites competition model using GraphPad Prism software.
All values were calculated as logIC 50 and reported as the IC 50 . 
| Association kinetics
| Data and statistical analysis
| Synthesis of [ 3 H]GMOM
Five to ten MBq of [ 3 H]GMOM were obtained per synthesis, with radiochemical yields ranging from 11 to 22%. The specific activity of the product was 3.13 TBq/mmol (84.5 Ci/mmol), and its radiochemical and chemical purity >99% (Figure 2 ). (Figure 4B ). For 
| Binding conditions
| Homologous inhibition assays
Saturation binding parameters were obtained by self-inhibition of Table 3 . 
| Heterologous inhibition assays
| Association kinetics
Association curves were constructed in the presence of 100 μmol Figure 7A) . The slow and fast rate constants did not follow a 
| Biphasic inhibition curves by ion-channel ligands
For [ 3 H]MK-801, the observed potency of inhibition by ketamine, 40, 41 memantine, 40, 42 GMOM, 13 and CNS-5161 43 
| CONCLUSIONS
We report on the synthesis and in vitro binding properties of [ 3 H] GMOM. Similar to MK-801 48 and the diarylguanidine tracers, 15, 39, 43, 49 GMOM is selective for the NMDA receptor ionophore. 
